BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25240552)

  • 1. Crushed stent with acute occlusion in superficial femoral artery after enhanced external counterpulsation.
    Suh Y; Ko YG; Lee SH; Kim MD; Choi D
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e141-2. PubMed ID: 25240552
    [No Abstract]   [Full Text] [Related]  

  • 2. Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.
    Yang X; Lu X; Li W; Huang Y; Huang X; Lu M; Jiang M
    J Vasc Surg; 2014 Aug; 60(2):362-8. PubMed ID: 24680242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Failed Crossover Stenting across the Ostium of the Deep Femoral Artery: Report of 2 Cases.
    Iwasaki T; Ogino H; Nishibe T
    Ann Vasc Surg; 2016 Apr; 32():128.e1-5. PubMed ID: 26724426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
    Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
    J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
    Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R
    J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-month results of the EverFlex stent in the superficial femoral artery.
    Diehl SJ; Gerblich F; Jochum S; Huck K; Keese M; Schoenberg SO; Sadick M
    J Vasc Interv Radiol; 2012 Oct; 23(10):1317-22. PubMed ID: 22840683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraprocedural Foot Embolization during In-Stent Restenosis Superficial Femoral Artery Recanalization: Plantar to Pedal Loop Aspiration Thrombectomy Technique Using the Penumbra MAX Catheter.
    Gandini R; Merolla S; Chegai F; Pratesi G; Abrignani S; Loreni G; Pistolese CA; Pampana E
    J Vasc Interv Radiol; 2016 Apr; 27(4):606-8. PubMed ID: 27013008
    [No Abstract]   [Full Text] [Related]  

  • 9. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
    J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
    Angle JF; Gasparetto A; Yokoi H; Jaff MR; Popma JJ; Piegari GN; Iyengar SS; Ohki T
    J Vasc Interv Radiol; 2020 Jun; 31(6):978-985. PubMed ID: 32414572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication.
    Schneider PA
    J Vasc Surg; 2017 Sep; 66(3):916-923. PubMed ID: 28842077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-Helix Stenting in 1 Superficial Femoral Artery.
    Jong BH; Soga Y
    JACC Cardiovasc Interv; 2018 Aug; 11(15):e121-e122. PubMed ID: 29778729
    [No Abstract]   [Full Text] [Related]  

  • 16. Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.
    Hillegass WB
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1096. PubMed ID: 19953522
    [No Abstract]   [Full Text] [Related]  

  • 17. Latest developments in SFA management.
    Minar E
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):451-3. PubMed ID: 24941244
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features and patency rates of Remedy
    Tiryakioglu SK; Tiryakioglu O; Karahan O; Demirtas S; Gokalp F; Erkoc K; Özkan H; Ozyazicioglu A
    Cardiovasc J Afr; 2016 Jul/Aug 23; 27(4):238-241. PubMed ID: 26813981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Vascular Complication of Transgender Reassignment Surgery.
    Russo N; Deitch J; Schor J; Saha S; Lachhar G; Singh K
    Ann Vasc Surg; 2020 Nov; 69():448.e15-448.e18. PubMed ID: 32474149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.